In a filing, Arcus Biosciences Inc revealed its Chief Operating Officer Jarrett Jennifer unloaded Company’s shares for reported $0.2 million on Mar 27 ’24. In the deal valued at $17.55 per share,11,551 shares were sold. As a result of this transaction, Jarrett Jennifer now holds 215,253 shares worth roughly $ 3.14 million.
Then, Jarrett Jennifer sold 13,449 shares, generating $240,941 in total proceeds. Upon selling the shares at $17.92, the Chief Operating Officer now owns 226,804 shares.
Before that, Jarrett Jennifer sold 34,070 shares. Arcus Biosciences Inc shares valued at $685,148 were divested by the Chief Operating Officer at a price of $20.11 per share. As a result of the transaction, Jarrett Jennifer now holds 240,253 shares, worth roughly $3.51 million.
BofA Securities initiated its Arcus Biosciences Inc [RCUS] rating to a Neutral in a research note published on November 18, 2022; the price target was $33. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid October with a ‘”an Overweight”‘ rating. Berenberg started covering the stock on November 24, 2020. It rated RCUS as “a Buy”.
Price Performance Review of RCUS
On Friday, Arcus Biosciences Inc [NYSE:RCUS] saw its stock fall -1.68% to $14.59. Over the last five days, the stock has lost -12.00%. Arcus Biosciences Inc shares have fallen nearly -23.61% since the year began. Nevertheless, the stocks have fallen -23.93% over the past one year. While a 52-week high of $25.47 was reached on 02/27/24, a 52-week low of $12.95 was recorded on 04/19/24. SMA at 50 days reached $17.49, while 200 days put it at $17.68. A total of 0.6 million shares were traded, compared to the trading of 0.91 million shares in the previous session.
Levels Of Support And Resistance For RCUS Stock
The 24-hour chart illustrates a support level at 14.06, which if violated will result in even more drops to 13.54. On the upside, there is a resistance level at 15.15. A further resistance level may holdings at 15.72. The Relative Strength Index (RSI) on the 14-day chart is 32.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.78, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.24%. Stochastics %K at 6.84% indicates the stock is a buying.
The most recent change occurred on November 23, 2020 when Evercore ISI began covering the stock and recommended ‘”an Outperform”‘ rating .
